Abstract
Human epidermal growth factor receptor 2 (HER2) overexpression is not only closely associated with the tumor growth, but is also related to tumor invasion. We here aimed to investigate the mechanism of HER2 mediation in the pathogenesis of gastric cancer. The human gastric cancer cell lines SGC-7901, MKN-45, AGS, the immortalized cell line GES-1 derived from normal gastric mucosa. Cell transfection and selection of stable cell lines and the gene and protein levels of HER2 and Matrix metalloproteinase-9 (MMP-9) were examined to determine the molecular relationship between them in the pathogenesis of gastric cancer. The human gastric cancer cell lines SGC-7901, MKN-45, AGS, the immortalized cell line GES-1 derived from normal gastric mucosa. Cell transfection and selection of stable cell lines and the gene and protein levels of HER2 and MMP-9 were examined to determine the molecular relationship between them in the pathogenesis of gastric cancer. We demonstrated that vector-based shRNA significantly knocked down the expression of HER2 and considerably inhibited both the migration and invasion of gastric cancer cells. HER2 knockdown resulted in the downregulation of the expression of MMP-9, whereas HER2 overexpression improved the transcription of MMP-9 through the activation of an MMP-9 promoter. The promoter region of MMP-9 between −2500 and −2000 bp was found to be crucial for the upregulation of HER2-mediated transcription. Furthermore, a truncated promoter (−70 to +63) did not display any transcriptional activity. Cell invasion activity was almost completely inhibited when MMP-9 was knocked down. Conversely, the overexpression of MMP-9 partly rescued the invasion ability of cell strains with knockdown HER2. These findings help further understanding of the molecular mechanisms through which HER2 promotes malignancy, and suggest that targeting both HER2 and MMP-9 may be required to effectively block HER2 signaling in gastric cancer therapy.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Chen J, Chen LJ, Zhou HC, Yang RB, Lu Y, Xia YL et al. Prognostic value of matrix metalloproteinase-9 in gastric cancer: a meta-analysis. Hepatogastroenterology 2014; 61: 518–524.
Yang Y, Bai ZG, Yin J, Wu GC, Zhang ZT . Role of c-Src activity in the regulation of gastric cancer cell migration. Oncol Rep 2014; 32: 45–49.
Li Y, Tan BB, Zhao Q, Fan LQ, Wang D, Liu Y . ZNF139 promotes tumor metastasis by increasing migration and invasion in human gastric cancer cells. Neoplasma 2014; 61: 291–298.
Yu SY, Li Y, Fan LQ, Zhao Q, Tan BB, Liu Y . Impact of Annexin A3 expression in gastric cancer cells. Neoplasma 2014; 61: 257–264.
Oo HZ, Sentani K, Sakamoto N, Anami K, Naito Y, Uraoka N et al. Overexpression of ZDHHC14 promotes migration and invasion of scirrhous type gastric cancer. Oncol Rep 2014; 32: 403–410.
Li XS, Xu Q, Fu XY, Luo WS . Heat shock protein 22 overexpression is associated with the progression and prognosis in gastric cancer. J Cancer Res Clin Oncol 2014; 140: 1305–1313.
Yang H, Wang B, Yan J, Wang T, Zhou XN, Wen HY et al. Toll-like receptor 2 promotes invasion by SGC-7901 human gastric carcinoma cells and is associated with gastric carcinoma metastasis. Ann Clin Lab Sci 2014; 44: 158–166.
Chang WJ, Du Y, Zhao X, Ma LY, Cao GW . Inflammation-related factors predicting prognosis of gastric cancer. World J Gastroenterol 2014; 20: 4586–4596.
Liu J, Liu Q, Wan Y, Zhao Z, Yu H, Luo H et al. Osteopontin promotes the progression of gastric cancer through the NF-κB pathway regulated by the MAPK and PI3K. Int J Oncol 2014; 45: 282–290.
Ojetti V, Persiani R, Cananzi FC, Sensi C, Piscaglia AC, Saulnier N et al. cDNA-Microarray Analysis as a New Tool to Predict Lymph Node Metastasis in Gastric Cancer. World J Surg 2014; 38: 2058–2064.
Zhang J, Wang P, Zhu J, Wang W, Yin J, Zhang C et al. SPARC expression is negatively correlated with clinicopathological factors of gastric cancer and inhibits malignancy of gastric cancer cells. Oncol Rep 2014; 31: 2312–2320.
Bubnovskaya L, Kovelskaya A, Gumenyuk L, Ganusevich I, Mamontova L, Mikhailenko V et al. Disseminated tumor cells in bone marrow of gastric cancer patients: correlation with tumor hypoxia and clinical relevance. J Oncol 2014; 2014: 582140.
Jiang B, Li Z, Zhang W, Wang H, Zhi X, Feng J et al. miR-874 Inhibits cell proliferation, migration and invasion through targeting aquaporin-3 in gastric cancer. J Gastroenterol 2014; 49: 1011–1025.
Zhang GE, Jin HL, Lin XK, Chen C, Liu XS, Zhang Q et al. Anti-tumor effects of mfn2 in gastric cancer. Int J Mol Sci 2013; 14: 13005–13021.
Kim YM, Kim IH, Nam TJ . Inhibition of AGS human gastric cancer cell invasion and proliferation by Capsosiphon fulvescens glycoprotein. Mol Med Rep 2013; 8: 11–16.
Li Y, Sun DL, Duan YN, Zhang XJ, Wang N, Zhou RM et al. Association of functional polymorphisms in MMPs genes with gastric cardia adenocarcinoma and esophageal squamous cell carcinoma in high incidence region of North China. Mol Biol Rep 2010; 37: 197–205.
Zhao FJ, Kang CS, Cui XW, Song XM, Liu J, Zhang QY . The relationship of MMP-9, VEGF and PCNA expressions and their clinical significance in gastric adenocarcinoma. Zhonghua Nei Ke Za Zhi 2009; 48: 114–117 Chinese.
Lukaszewicz-Zajac M, Mroczko B, Szmitkowski M . The significance of metalloproteinases and their inhibitors in gastric cancer. Postepy Hig Med Dosw (Online) 2009; 63: 258–265 Review. Polish.
Adachi Y, Li R, Yamamoto H, Min Y, Piao W, Wang Y et al. Insulin-like growth factor-I receptor blockade reduces the invasiveness of gastrointestinal cancers via blocking production of matrilysin. Carcinogenesis 2009; 30: 1305–1313.
Vecchione L, Orditura M, Ciardiello F, De Vita F . Novel investigational drugs for gastric cancer. Expert Opin Investig Drugs 2009; 18: 945–955.
Du R, Xia L, Sun S, Lian Z, Zou X, Gao J et al. URG11 promotes gastric cancer growth and invasion by activation of beta-catenin signalling pathway. J Cell Mol Med 2010; 14: 621–635.
Kamata I, Ishikawa Y, Akishima-Fukasawa Y, Ito K, Akasaka Y, Uzuki M et al. Significance of lymphatic invasion and cancer invasion-related proteins on lymph node metastasis in gastric cancer. J Gastroenterol Hepatol 2009; 24: 1527–1533.
Peng CW, Wang LW, Fang M, Yang GF, Li Y, Pang DW . Combined features based on MT1-MMP expression, CD11b+immunocytes density and LNR predict clinical outcomes of gastric cancer. J Transl Med 2013; 11: 153.
Park SH, Hong H, Han YM, Kangwan N, Kim SJ, Kim EH et al. Nonsteroidal anti-inflammatory drugs (NSAID) sparing effects of glucosamine hydrochloride through N-glycosylation inhibition; strategy to rescue stomach from NSAID damage. J Physiol Pharmacol 2013; 64: 157–165.
Chen HJ, Lin CM, Lee CY, Shih NC, Amagaya S, Lin YC et al. Phenethyl isothiocyanate suppresses EGF-stimulated SAS human oral squamous carcinoma cell invasion by targeting EGF receptor signaling. Int J Oncol 2013; 43: 629–637.
Song W, Zhao C, Jiang R . Integrin-linked kinase silencing induces a S/G2/M phases cell cycle slowing and modulates metastasis-related genes in SGC7901 human gastric carcinoma cells. Tumori 2013; 99: 249–256.
Wang G, Wang W, Zhou J, Yang X . Correlation between telomerase activity and matrix metalloproteinases 2 expression in gastric cancer. Cancer Biomark 2013; 13: 21–28.
Ke P, Wu ZD, Wen HS, Ying MX, Long HC, Qing LG . Current evidence on associations between the MMP-7 (-181A>G) polymorphism and digestive system cancer risk. Asian Pac J Cancer Prev 2013; 14: 2269–2272.
Wen YG, Wang Q, Zhou CZ, Qiu GQ, Peng ZH, Tang HM . Mutation analysis of tumor suppressor gene PTEN in patients with gastric carcinomas and its impact on PI3K/AKT pathway. Oncol Rep 2010; 24: 89–95.
Liu QS, Zhang J, Liu M, Dong WG . Lentiviral-mediated miRNA against liver-intestine cadherin suppresses tumor growth and invasiveness of human gastric cancer. Cancer Sci 2010; 101: 1807–1812.
Kang D, Gong Y, Zhu Y, Li A, Dong N, Piao Y et al. The biological activity of H. pylori SlyD in vitro. Helicobacter 2013; 18: 347–355.
Emara M, Cheung PY, Grabowski K, Sawicki G, Wozniak M . Serum levels of matrix metalloproteinase-2 and -9 and conventional tumor markers (CEA and CA 19-9) in patients with colorectal and gastric cancers. Clin Chem Lab Med 2009; 47: 993–1000.
Buergy D, Fuchs T, Kambakamba P, Mudduluru G, Maurer G, Post S et al. Prognostic impact of extracellular matrix metalloprotease inducer: immunohistochemical analyses of colorectal tumors and immunocytochemical screening of disseminated tumor cells in bone marrow from patients with gastrointestinal cancer. Cancer 2009; 115: 4667–4678.
Peng TL, Chen J, Mao W, Song X, Chen MH . Aryl hydrocarbon receptor pathway activation enhances gastric cancer cell invasiveness likely through a c-Jun-dependent induction of matrix metalloproteinase-9. BMC Cell Biol 2009; 10: 27.
Nomura T, Kamio Y, Takasu N, Moriya T, Takeshita A, Mizutani M et al. Intrahepatic micrometastases around liver metastases from gastric cancer. J Hepatobiliary Pancreat Surg 2009; 16: 493–501.
Achyut BR, Ghoshal UC, Moorchung N, Mittal B . Transforming growth factor-B1 and matrix metalloproteinase-7 promoter variants induce risk for Helicobacter pylori-associated gastric precancerous lesions. DNA Cell Biol 2009; 28: 295–301.
Fu Y, Zhang Q, Kang C, Zhang J, Zhang K, Pu P et al. Inhibitory effects of adenovirus mediated Akt1 and PIK3R1 shRNA on the growth of malignant tumor cells in vitro and in vivo. Cancer Biol Ther 2009; 8: 1002–1009.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Shan, YQ., Ying, RC., Zhou, CH. et al. MMP-9 is increased in the pathogenesis of gastric cancer by the mediation of HER2. Cancer Gene Ther 22, 101–107 (2015). https://doi.org/10.1038/cgt.2014.61
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/cgt.2014.61
This article is cited by
-
The changing face of gastric cancer: epidemiologic trends and advances in novel therapies
Cancer Gene Therapy (2021)
-
Double power-law viscoelastic relaxation of living cells encodes motility trends
Scientific Reports (2020)
-
Helicobacter pylori infection and gastric cancer biology: tempering a double-edged sword
Cellular and Molecular Life Sciences (2019)
-
CUL4B promotes gastric cancer invasion and metastasis-involvement of upregulation of HER2
Oncogene (2018)
-
Serum HER2 extra-cellular domain, S100ß and CA 15-3 levels are independent prognostic factors in metastatic breast cancer patients
BMC Cancer (2016)